Phase I Chinese PK
An open, phase 1 to assess the PK of rising doses of ZD6474 when administered daily in Chinese patients with advanced solid malignant tumors.
Advanced Solid, Malignant Tumors
DRUG: Vandetanib|DRUG: Vandetanib 300 mg
Area under the curve (AUC) (0-24) (ng.h/mL) after single dose, Blood sample is collected at 1, 2, 4, 6, 8, 10 & 24 hour after first single dose on day 1
An open, phase 1 to assess the PK of rising doses of ZD6474 when administered daily in Chinese patients with advanced solid malignant tumors.